Full Text
Cost-Effectiveness of Elbasvir/Grazoprevir Versus Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir (3D Regimen) for Treatment of Chronic Hepatitis C Genotype 1B Patients in China

Abstract

Authors

PY Chen Q Liu HC Li AX Ma

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×